Stocks
Blueprint Medicines Corporation (BPMC) Debt/EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| Debt/EBITDA | 1.27 | -4.73 | 1.47 | 1.62 | -0.13 | 1.09 | ||
| Changes by years, y/y, % | -37% | -473% | -131% | +10% | -108% | |||
Blueprint Medicines Corporation. Debt/EBITDA
Blueprint Medicines Corporation. Debt/EBITDA, changes, %
Blueprint Medicines Corporation (BPMC) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 1.36 | -0.14 | 0.12 | 0.07 | 1.09 | 1.09 | ||
| Changes by years, y/y, % | +6% | -109% | -92% | -95% | -20% | |||
| Changes by quarters, q/q, % | -1% | -110% | -188% | -39% | +1 414% | |||
